SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-022492
Filing Date
2024-07-10
Accepted
2024-07-10 16:53:26
Documents
16
Period of Report
2024-07-03
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240710_8k.htm   iXBRL 8-K 32740
2 EXHIBIT 4.1 ex_696943.htm EX-4.1 165638
3 EXHIBIT 4.2 ex_696944.htm EX-4.2 203795
  Complete submission text file 0001437749-24-022492.txt   626803

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wint-20240703.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240703_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240703_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240703_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT wint20240710_8k_htm.xml XML 2839
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241110442
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)